Comparison of Single Course High-Dose Dexamethasone and Prednisone for Initial Treatment of Primary Immune Thrombocytopenia in Children: A Prospective Randomized Trial

Journal Title: IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) - Year 2017, Vol 16, Issue 10

Abstract

Introduction: Prednisone (PDN) is the most commonly used first-line treatment for primary immune thrombocytopenia (ITP) in children. Recently, a short-course high-dose dexamethasone (HD-DXM) therapy has been reported to be efficacious in childhood primary ITP. However, the choice of best corticosteroid as an initial therapy in primary ITP in children is still a matter of debate. Methods: This single-blind prospective randomized clinical trial was conducted at Pediatrics Department, NRS Medical College and Hospital, Kolkata, a tertiary care teaching institute in the state of West Bengal from the month of July 2014 to June 2017 to compare the efficacy and safety of HD-DXM and conventional PDN as firstline strategies for newly diagnosed primary ITP in children. Patients enrolled were randomized to receive DXM 20 mg/m2 /day for 4 days (n=49) or PDN 2.0 mg/kg/day for 10 day and then tapered over 2-3 weeks (n=47). Results: Single courses of HD-DXM resulted in a higher incidence of overall initial response (95.92% vs 82.98%, P = 0.049) and complete response (69.39% vs 34.04%, P = 0.001) compared with prednisone. Median time to response was shorter in the HD-DXM group [4 days (1-6) vs 6 days (2-9), P = < 0.0001). Bleeding was more effectively controlled on day 3 (P = 0.009) in children who had received HD-DXM compared with prednisone. Sustained response was achieved in 71.43% of patients in the HD-DXM arm and 42.55% in the PDN arm (P = 0.007). Initial complete response was associated with a decreased likelihood of loss of response. Both the corticosteroids were tolerated better with no statistically significant difference regarding treatment related overall toxicities (P = 0.0604). Conclusion: We concluded that HD-DXM could be a preferred corticosteroid strategy for first-line management of primary ITP in children.

Authors and Affiliations

Radheshyam Purkait, Rajarshi Basu

Keywords

Related Articles

Bacteriological Profile ofBlood Culture Positive Sepsis inNeonatesin A Tertiary Care Centre.

This prospective study was conducted in SNCU of GMCH to find out the bacteriological profile of neonatal sepsis and their sensitivity. In 93(13.64%) neonates out of 682 neonates, organisms were isolated. 56(60.22%) neona...

Prevalence of Depression in Temporomandibular Joint Disorder: A Cross-Sectional Study

Background: Temporomandibular joint disorders (TMDs) causes a problem in chewing system which is comprised of the temporomandibular joint and soft tissue around it. Aim: The present study aimed to explore the relationshi...

“Recurrence Following Chemoradiation in Locally Advanced Head and Neck Carcinoma – An Institutional Experience”

The main objective of our study is to describe the pattern of recurrence in locally advanced head and neck cancer patients treated with chemoradiationat Father Muller Medical College Hospital, Mangalore, India. Thirty pa...

Diagnostic Value of Procalcitonin Levels Compared to Leukocyte and CRP Levels in Detecting Acute Perforated Appendicitis in Children at Saiful Anwar Hospital Malang

Appendicitis is an acute abdominal case in children often found in surgical clinical practice. Specific and accurate diagnostic methods for predicting acute and perforated appendicitis in children have not been establish...

A Practical Approach to Fatigue Patients in Tertiary Care Hospitals- Aprospective Study

Fatigue is a subjective feeling of tiredness which is distinct from weakness, and has a gradual onset. Unlike weakness, fatigue can be alleviated by periods of rest. Fatigue can have physical or mental causes.Fatigue is...

Download PDF file
  • EP ID EP239178
  • DOI 10.9790/0853-1610014955
  • Views 86
  • Downloads 0

How To Cite

Radheshyam Purkait, Rajarshi Basu (2017). Comparison of Single Course High-Dose Dexamethasone and Prednisone for Initial Treatment of Primary Immune Thrombocytopenia in Children: A Prospective Randomized Trial. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), 16(10), 49-55. https://europub.co.uk/articles/-A-239178